144 related articles for article (PubMed ID: 20452911)
1. Comparison of a pharmacist-managed lipid clinic: in-person versus telephone.
Dolder NM; Dolder CR
J Am Pharm Assoc (2003); 2010; 50(3):375-8. PubMed ID: 20452911
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center.
Fabbio KL; Bradley M; Chrymko M
Ann Pharmacother; 2010 Jan; 44(1):50-6. PubMed ID: 20028961
[TBL] [Abstract][Full Text] [Related]
3. Development of a pharmacist-managed lipid clinic.
Cording MA; Engelbrecht-Zadvorny EB; Pettit BJ; Eastham JH; Sandoval R
Ann Pharmacother; 2002 May; 36(5):892-904. PubMed ID: 11978169
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.
Collins C; Kramer A; O'Day ME; Low MB
Am J Health Syst Pharm; 2006 Sep; 63(18):1723-7. PubMed ID: 16960256
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
Smith MC; Boldt AS; Walston CM; Zillich AJ
Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
Till LT; Voris JC; Horst JB
J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
[TBL] [Abstract][Full Text] [Related]
7. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
Mazzolini TA; Irons BK; Schell EC; Seifert CF
J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing.
Gerrald KR; Dixon DL; Barnette DJ; Williams VG
J Clin Lipidol; 2010; 4(2):120-5. PubMed ID: 21122639
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
Lee VW; Fan CS; Li AW; Chau AC
J Clin Pharm Ther; 2009 Aug; 34(4):407-14. PubMed ID: 19583673
[TBL] [Abstract][Full Text] [Related]
10. Can group medical clinics improve lipid management in diabetes?
Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD.
Aspinall SL; Cunningham FE; Zhao X; Boresi JS; Tonnu-Mihara IQ; Smith KJ; Stone RA; Good CB;
Am J Kidney Dis; 2012 Sep; 60(3):371-9. PubMed ID: 22633556
[TBL] [Abstract][Full Text] [Related]
12. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
13. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.
Bozovich M; Rubino CM; Edmunds J
Pharmacotherapy; 2000 Nov; 20(11):1375-83. PubMed ID: 11079286
[TBL] [Abstract][Full Text] [Related]
14. Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.
Rehring TF; Stolcpart RS; Sandhoff BG; Merenich JA; Hollis HW
J Vasc Surg; 2006 Jun; 43(6):1205-10. PubMed ID: 16765240
[TBL] [Abstract][Full Text] [Related]
15. Correlates of repeat lipid testing in patients with coronary heart disease.
Virani SS; Woodard LD; Wang D; Chitwood SS; Landrum CR; Urech TH; Pietz K; Chen GJ; Hertz B; Murawsky J; Ballantyne CM; Petersen LA
JAMA Intern Med; 2013 Aug; 173(15):1439-44. PubMed ID: 23817669
[TBL] [Abstract][Full Text] [Related]
16. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
Shaffer J; Wexler LF
Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
[TBL] [Abstract][Full Text] [Related]
17. Achieving cholesterol target in a managed care organization (ACTION) trial.
Straka RJ; Taheri R; Cooper SL; Smith JC
Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
[TBL] [Abstract][Full Text] [Related]
18. Patterns and effectiveness of lipid-lowering therapies in a managed care environment.
Meyer JW; Schultz JS; O'Donnell JC; Patel PA; Sasane RM
Value Health; 2005; 8(5):601-12. PubMed ID: 16176498
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.
Ellis SL; Carter BL; Malone DC; Billups SJ; Okano GJ; Valuck RJ; Barnette DJ; Sintek CD; Covey D; Mason B; Jue S; Carmichael J; Guthrie K; Dombrowski R; Geraets DR; Amato M
Pharmacotherapy; 2000 Dec; 20(12):1508-16. PubMed ID: 11130223
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
